|
DAVI SKIN, INC. - 10QSB - 20041122 - INCOME_STATEMENT
DAVISKIN, INC.
(formerly MW Medical, Inc.)
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
|
For the
|
|
Period from
|
|
March 21, 2004
|
|
Three Date of inception
|
|
Months ended through
|
|
September 30, September 30
|
|
2004 2004
|
|
|
|
|
|
|
|
|
Revenues
|
$
|
0
|
|
$
|
0
|
|
Cost of revenues
|
|
0
|
|
|
0
|
|
|
|
|
|
|
|
|
Gross profit (Loss)
|
|
0
|
|
|
0
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
|
|
|
|
Selling, general and administrative
|
|
52,126
|
|
|
227,882
|
|
Depreciation
|
|
1,229
|
|
|
2,228
|
|
Consulting fees
|
|
716,848
|
|
|
716,848
|
|
Professional fees
|
|
524,784
|
|
|
524,784
|
|
|
|
1,294,987
|
|
|
1,471,742
|
|
|
|
|
|
|
|
|
Income (Loss) From Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expenses)
|
|
|
|
|
|
|
Interest expenses
|
|
(5,000
|
)
|
|
(5,000)
|
|
Interest income
|
|
2,519
|
|
|
3,393
|
|
|
|
(2,481
|
)
|
|
(1,607)
|
|
|
|
|
|
|
|
|
NET INCOME (LOSS)
|
|
(1,297,468
|
)
|
|
(1,473,349)
|
|
|
|
|
|
|
|
|
Basic income (loss) per common share
|
$
|
(0.12
|
)
|
$
|
(0.14)
|
|
|
|
|
|
|
|
|
Diluted income (loss) per common share
|
$
|
(0.12
|
)
|
$
|
(0.14)
|
|
|
|
|
|
|
|
|
Basic weighted average common shares outstanding
|
|
1,691,491
|
|
|
10,105,257
|
|
|
|
|
|
|
|
|
Diluted weighted average common shares outstanding
|
|
11,090,291
|
|
|
10,504,057
|
|
|
|
|
|
|
|
See Accompanying Notes to Consolidated Financial Statements.
|
|
Next Section
Previous Section